Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

201

HTML

2042

Tables (1-3)

118

Sum=2361

Jul 15, 2003 (publication date) through Apr 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jul 15, 2003; 9(7): 1487-1490
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1487

Table 3 Organ-specific and non-organ-specific autoantibodies

	Before IFN + (%)	IFN withdrawal + (%)	12 mo after withdrawal+(%)
Organ-specific antibodies
TPO	14 (8.0%)	39 (20.6%)^a	23 (12.2%)
Non-organ-specific antibodies
ANA	34 (18.0%)	45 (24.0%)	41 (22.0%)
SMA	56 (30.0%)	62 (33.0%)	60 (31.0%)
AMA	-	1 (0.5%)	1 (0.5%)
LMK 1	1 (0.5%)	3 (1.6%)	2 (1.1%)

^aP < 0.001 vs before IFN; P = 0.036 vs 12 mo after IFN withdrawal.

Citation: Fabbri C, Jaboli MF, Giovanelli S, Azzaroli F, Pezzoli A, Accogli E, Liva S, Nigro G, Miracolo A, Festi D, Colecchia A, Montagnani M, Roda E, Mazzella G. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. World J Gastroenterol 2003; 9(7): 1487-1490
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1487.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1487